NOS2 and viral infectious disease: Due to the overlap in immunosuppressive mechanisms of iNOS- and/or Arg1-expressing suppressor cells, therapeutic strategies under development to limit the immunosuppressive effects of myeloid cells in cancer may be beneficial in treating persistent/chronic virus infections.